Trader Brian Jones on Twitter: "$INMB INmune Bio shares are trading higher after the company announced clinical data that demonstrated XPro1595, its lead drug candidate, decreased neuroinflammation in patients with Alzheimer's disease. Jul 13, 2020 4:21p ETBenzinga Stock Analysis" / Twitter

$INMB INmune Bio shares are trading higher after the company announced clinical data that demonstrated XPro1595, its lead drug candidate, decreased neuroinflammation in patients with Alzheimer's disease. Jul 13, 2020 4:21p ETBenzinga Stock Analysis

9:40 PM · Jul 13, 2020Twitter Web App

Retweet

Likes

Conversation